ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2681

Physical Function, Sleep, Depression but Not CRP Level Is Associated with Fatigue in Patients with Established Rheumatoid Arthritis

Yong Gil Hwang1, Juan (June) Feng2, Heather Eng2, Jason Lyons2, Anthony Fabio3 and Larry W. Moreland4, 1Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 3Department Of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 4Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: C-reactive protein (CRP), Fatigue, physical function and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is
characterized by inflammation of the joints and fatigue. Although many studies
have identified risk factors for RA-associated fatigue, few studies have comprehensively
examined the role of C – reactive protein (CRP) on fatigue. We investigated the
association of CRP on fatigue using the Patient Reported Outcomes Measurement
Information System (PROMIS) in a cohort of patients with RA.

Methods:
 RA
subjects enrolled in the University of Pittsburgh Rheumatoid Arthritis
Comparative Effectiveness Registry (RACER) and who completed the PROMIS29
questionnaire were included (N=180). RA specific risk factors (disease activity
measured by the Clinical Disease Activity Index [CDAI], physical function, RA
treatment [conventional Disease Modifying Anti-Rheumatic Drugs (DMARD), anti –
tumor necrosis factor [TNF], other biologics, disease duration, pain level),
non-RA risk factors (sleep, anxiety, depression, Charlson comorbidity index) as
well as CRP  were assessed using descriptive statistics to summarize the
distribution of the variables. Fatigue identified by PROMIS29 was the primary
outcome.  Spearman correlations and univariate analyses were first conducted
to evaluate associations with fatigue. Multiple linear regression analyses were
performed to investigate whether CRP is an independent predictor of fatigue.
Mediation analysis was performed to explore if there is any indirect
relationship between CRP level and factors associated with fatigue.

Results:   Mean (±SD) subject age was 63.9
(±12.2) years with disease duration of 7.7 (± 0.8) years. Univariate analyses
identified 7 covariates (age, CDAI score, global pain intensity, physical
function, sleep, anxiety, depression) initially as potential predictors of
fatigue. In multivariate analyses, physical function, sleep, and depression
were independently associated with fatigue, but CRP or RA treatments did not
have significant association with fatigue. (Table.1) CRP was inversely
correlated with physical function (ρ
= -0.23, p=0.016). However, there was no mediation effect between CRP and
physical function in association with fatigue.

Conclusion:    Out study suggests
that poor sleep, decreased physical function, and depression have significant
effect on fatigue. CRP level was not associated with fatigue directly or
indirectly.

  

Table.1 Rheumatoid arthritis (RA)-specific and non -RA specific risk factors  for fatigue (CDAI: Clinical Disease Activity Index, CRP: C-Reactive Protein, TNF: Tumor Necrosis Factor)

 

 

Mean (SD) or N

RA specific risk factors

CDAI

10.28 (8.14)

Disease duration

18.03 (13.52)

CRP (mg/dL)

0.77 (0.92)

Pain level (global pain intensity 0-10)

4.30 (2.54)

Treatment

 

 DMARD (N)

96

Anti-TNF (N)

11

Non-TNF biologics (N)

9

Non-RA risk factors

Sleep (t score)

50.82 (8.09)

Anxiety (t score)

51.04 (9.56)

Depression (t score)

49.53 (8.80)

Comorbidity index

2.32 (2.00)

 

Table.2 Associations of fatigue with RA specific and non-RA specific factors by multiple linear regression analyses. Among RA associated and non-RA associated risk factors, 4 variables identified by univariate analyses were included in Model 1.  Model 2 was adjusted as model 1 plus CRP and RA treatment. (β unstandardized coefficient, SE : Standard Error).

Model

Variables

Fatigue

β

SE

p value

1

Physical function

-0.38813     

0.07199  

. <.0001

Age

-0.11267     

0.04882   

0.0223

Sleep

0.31284

0.07318   

<.0001

Depression

0.37075     

0.07060  

<.0001

2

Physical function

-0.40934       

0.09867     

<.0001

Age

-0.11650       

0.06712     

0.0856

Sleep

0.35516       

0.09857      

0.0005

Depression

0.39728       

0.09954      

0.0001

CRP

-1.13464       

0.82493     

0.1720

DMARD

-0.47791       

1.54109     

0.7571

Anti-TNF

0.36249       

4.05218      

0.9289

Non-TNF biologics

2.43892       

4.16328      

0.5593

 


Disclosure: Y. G. Hwang, None; J. Feng, None; H. Eng, None; J. Lyons, None; A. Fabio, None; L. W. Moreland, None.

To cite this abstract in AMA style:

Hwang YG, Feng J, Eng H, Lyons J, Fabio A, Moreland LW. Physical Function, Sleep, Depression but Not CRP Level Is Associated with Fatigue in Patients with Established Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/physical-function-sleep-depression-but-not-crp-level-is-associated-with-fatigue-in-patients-with-established-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-function-sleep-depression-but-not-crp-level-is-associated-with-fatigue-in-patients-with-established-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology